Markets › India › NSE › ORCHPHARMA

Orchid Pharma Ltd

NSE:ORCHPHARMAHealthcare

₹893.50−1.95%At closeAt close · Mon 19 Oct · ≈ AED 34.52 · Market cap $574.08M · Next earnings Mon 16 Nov

Ratio	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	Current · undated	YoY
Gross margin	46.4%	41.5%	10.6%	16.6%	38.5%	19.5%	—	—
Operating margin	−11.2%	−6.1%	4.5%	9.5%	8.8%	0.7%	0.7%	+0.0 pts
Net margin	−25.9%	−0.3%	7.0%	11.3%	10.8%	2.5%	2.5%	+0.0 pts
EBITDA margin	14.4%	11.1%	21.5%	17.3%	15.7%	5.1%	—	—
Return on equity	−17.8%	−0.3%	6.7%	7.9%	7.9%	1.6%	1.6%	+0.0 pts
Return on assets	−9.4%	−0.2%	3.8%	5.9%	5.9%	1.1%	1.1%	+0.0 pts
Return on capital employed	−4.6%	−3.9%	3.5%	6.0%	5.8%	0.3%	—	—
Debt / equity	0.7×	0.4×	0.5×	0.1×	0.1×	0.3×	0.3×	+0.0%
Debt / assets	36.6%	24.1%	27.0%	8.7%	10.3%	19.0%	—	—
Interest coverage	−1.0×	−1.0×	0.9×	4.6×	5.6×	0.4×	—	—
Current ratio	3.9×	1.7×	1.3×	3.0×	2.8×	2.5×	2.5×	+0.0%
Quick ratio	2.8×	0.9×	0.7×	2.0×	1.7×	1.5×	—	—
Cash ratio	0.1×	0.0×	0.1×	0.0×	0.1×	0.0×	0.0×	+0.0%
Asset turnover	0.4×	0.5×	0.5×	0.5×	0.5×	0.4×	—	—
Inventory turnover	1.6×	1.9×	2.6×	2.6×	1.7×	2.5×	—	—
Receivables turnover	3.3×	3.3×	3.1×	4.1×	3.8×	3.1×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—

Margins, returns, leverage and liquidityUpdated Tue 31 Mar ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.